出处
《临床荟萃》
CAS
2010年第2期164-167,共4页
Clinical Focus
基金
国家科技基础条件平台工作重点项目(2005DKA21202-6)
河北省卫生厅医学重点课题(08075)
参考文献27
-
1Zhao X, Drlica K. Restricting the selection of antibioticresistant mutants: a general strategy derived from fluoroquinolone studies[J]. Clin Infect Dis, 2001,33 (Suppl 3) : 147-156.
-
2Zhao X, Drlica K. Restricting the selection of antibioticresistant mutants: measurement and potential uses of themutant selection window[J]. J Infect Dis, 2002, 185(4): 561-565.
-
3Dong Y, Zhao X, Domagala J, et al. Effect of fluoroquinolone concentration on selection of resistant mutants of Mycobacterium bovis BCG and Staphylococcus aureus [J ]. Antimicrob Agents Chemother, 1999,43(7) :1756-1758.
-
4Davidson R, Cavalcanti R, Brunton JL, et al. Resistance to levofloxacin and failure of treatment of pneumococeal pneumonia[J]. N Engl J Med,2002,346(10):747-750.
-
5Sieradzki K, Leski T, Dick J, et al. Evolution of a vancomycinintermediate Staphylococcus aureus strain in vivo: multiple changes in the antibiotic resistance phenotypes of a single lineage of methicillin-resistant S. aureus under the impact of antibiotics administered for chemotherapy [ J ]. J Clin Microbiol, 2003,41 (4) : 1687-1693.
-
6Howden BP, Stinear TP, Allen DL, et al. Genomic analysis reveals a point rnntation in the two-component sensor gene graS that leads to intermediate vancomycin resistance in clinical Staphylococcus aureus[J]. Antimicrob Agents Chemother, 2008,52 (10):3755- 3762.
-
7Zhou J ,Dong Y, Zhao X, et al. Selection of antibiotic resistant bacterial mutants: allelic diversity among fluoroquinoloneresistant mutations[J]. J Infect Dis, 2000,182 (2) :517 -525.
-
8Sindelar G, Zhao X, Liew A, et al. Mutant prevention concentration as a measure of fluoroquinolone potency against mycobacteria [J]. Antimicrob Agents Chemother, 2000, 44 (12) :3337-3343.
-
9Li X, Mariano N. Rahal JJ, et al. Quinolone-resistant Haemophilus influenzae: determination of mutant selection window for ciprofloxacin, garenoxacin, levofloxacin, and moxifloxacin[J]. Antimicrob Agents Chemother, 2004, 48 (11) :4460 -4462.
-
10Quinn B, Hussain S, Malik M, et al. Daptomycin inoculum effects and mutant prevention concentration with Staphylococcus aureus [J]. J Antimicrob Chemother, 2007,60 (6) : 1380-1383.
二级参考文献20
-
1谢林,刘晓东,王大为.注射用阿奇霉素的生物利用度研究[J].江苏药学与临床研究,2004,12(3):12-14. 被引量:1
-
2崔俊昌,刘又宁,王睿,梁蓓蓓,裴斐,郑专杰.4种氟喹诺酮类药物对金黄色葡萄球菌的防耐药变异浓度[J].中华医学杂志,2004,84(22):1863-1866. 被引量:34
-
3童卫杭,柴栋,崔俊昌,陈锟,王睿.兔感染性模型组织液中左氧氟沙星浓度HPLC测定[J].中国抗生素杂志,2005,30(12):759-761. 被引量:6
-
4崔俊昌,刘又宁,王睿杭,童卫杭,李朝霞.左氧氟沙星对兔组织笼金黄色葡萄球菌感染的疗效研究[J].中国临床药理学与治疗学,2007,12(3):291-294. 被引量:7
-
5[1]Zhao X,Drlica K.Restricting the selection of antibiotic-resistant mutants:a general strategy derived from fluoroquinolones studies.Clin Infect Dis,2001,33(Suppl):S147-S156.
-
6[2]Drlica K.The mutant selection window and antimicrobial resistance.J Antimicrob Chemother,2003,52:11-17.
-
7[6]Croisier D,Etienne M,Bergoin E,et al.Mutant selection window in levofloxacin and moxifloxacin treatments of experimental pneumococcal pneumonia in a rabbit model of human therapy.Antimicrob Agents Chemother,2004,48:1699-1707.
-
8[7]Croisier D,Etienne M,Piroth L,et al.In vivo pharmacodynamic efficacy of gatifloxacin against Streptococcus pneumoniae in an experimental model of pneumonia:impact of the low levels of fluoroquinolone resistance on the enrichment of resistant mutants.J Antimicrob Chemother,2004,54:640-647.
-
9[8]Etienne M,Croisier D,Charles PE,et al.Effect of low-level resistance on subsequent enrichment of fluoroquinolone-resistant Streptococcus pneumoniae in rabbits.J Infec Dis,2004,190:1472-1475.
-
10Drlica K.The mutant selection concentration and antimicrobial resistance[J].J Antimicrob Chemotherk,2003;52:11-17.
共引文献18
-
1刘同华,邢茂,宋光伟,王涵.细菌耐药突变选择窗理论的研究与应用[J].药学服务与研究,2009,9(1):9-12. 被引量:6
-
2庞露,刘晓东,肇丽梅,菅凌燕.抗菌药物防突变浓度理论与研究进展[J].中国医院药学杂志,2010,30(3):236-239. 被引量:1
-
3宋秀杰,刘又宁,王睿.抗菌药物防细菌耐药突变浓度理论及研究进展[J].药物评价研究,2010,33(1):13-18. 被引量:11
-
4李绍红,李泽民.细菌耐药突变选择窗与抗感染药物防突变浓度的研究与应用[J].检验医学与临床,2010,7(10):992-997.
-
5庚俐莉,戴冰冰,江玲,刘春芳,范艳平.左氧氟沙星单用及联合用药对细菌突变选择窗影响的研究[J].临床肺科杂志,2011,16(5):674-676. 被引量:3
-
6李虹,叶云,王国俊.耐药突变选择窗理论的研究与意义[J].泸州医学院学报,2011,34(6):758-761.
-
7王巍,李杰,刘耀川,王秋霞,田凯,刘明春.细菌对抗菌药物敏感性测定的新方法[J].黑龙江畜牧兽医,2012(3):26-28.
-
8孙雪娟,谢清波,陈忠秀,王艺影,于启华.结核病患者医院获得性金黄色葡萄球菌感染110例耐药性分析[J].医学检验与临床,2012,23(2):31-33. 被引量:4
-
9王国俊,叶云,李虹.中药影响左氧氟沙星对金黄色葡萄球菌的耐药突变选择窗的初步研究[J].中国药房,2012,23(39):3659-3661. 被引量:2
-
10李虹,叶云,王国俊.3种中药注射液突变选择窗的测定[J].重庆医学,2013,42(6):690-692. 被引量:1
同被引文献15
-
1崔俊昌,刘又宁,王睿,梁蓓蓓,裴斐,郑专杰.4种氟喹诺酮类药物对金黄色葡萄球菌的防耐药变异浓度[J].中华医学杂志,2004,84(22):1863-1866. 被引量:34
-
2李朝霞,刘又宁,王睿,童卫杭,程仕虎.几种抗菌药物在不同浓度时对金黄色葡萄球菌耐药突变株选择的影响[J].中国临床药理学与治疗学,2007,12(2):163-167. 被引量:12
-
3赵建宏,秦小霞,李静,时东彦,王鑫,李继红,赵宝珍,宋文杰,张立志,赵捷,岳云升.金黄色葡萄球菌临床分离株对万古霉素敏感性的监测[J].临床荟萃,2009,24(1):33-36. 被引量:6
-
4程宝艳,张丹俊,彭明义,程帮照,戴银.细菌黏附素研究进展[J].畜牧与饲料科学,2009,30(2):3-5. 被引量:8
-
5胡晖,唐清.万古霉素和利奈唑胺对耐甲氧西林金黄色葡萄球菌防耐药变异浓度的测定[J].实用预防医学,2010,17(2):374-375. 被引量:6
-
6喻婷,梅清,朱玉林,程君,叶英,李家斌.万古霉素联合用药降低对金黄色葡萄球菌防耐药突变浓度的研究[J].中国抗生素杂志,2011,36(11):859-863. 被引量:10
-
7孙长鲛,周勇刚.关节置换术后耐甲氧西林金黄色葡萄球菌感染的研究进展[J].中华医院感染学杂志,2014,24(12):3118-3120. 被引量:12
-
8蔡淑梅,朱海平,乔秀梅,金凤玲.万古霉素琼脂平板对异质性万古霉素中介金黄色葡萄球菌筛查价值的Meta分析[J].中国抗生素杂志,2015,40(3):213-216. 被引量:4
-
9柯邵鹏,刘江福,苏智军,郭如意,陈素梅,林琪.利奈唑胺与万古霉素治疗耐甲氧西林金黄色葡萄球菌感染疗效及安全性荟萃分析[J].中华医院感染学杂志,2015,25(6):1281-1284. 被引量:33
-
10时东彦,赵建宏,李志荣,李继红,曹丽军,孙艳,王迁,崔幸坤,谢守军,冯军,赵文申,陈玉兰,李洪臣,郭映辉,冯忠军,张金艳,张征,李士英,安翠萍,李书君,王雁勇.2013年河北省细菌耐药监测网三级甲等医院细菌耐药性监测[J].临床荟萃,2015,30(9):965-969. 被引量:10
引证文献3
-
1李静,刘晓雷,强翠欣,石磊,赵建宏.5株万古霉素敏感性减低耐甲氧西林金黄色葡萄球菌的graS基因及细胞超微结构分析[J].临床荟萃,2017,32(5):405-408.
-
2李静,赵建宏,刘晓雷,强翠欣,张庶民.万古霉素和利奈唑胺对56株MRSA防耐药变异浓度的比较[J].国际检验医学杂志,2017,38(23):3310-3311. 被引量:1
-
3张佩,李婉莹,关桐旭,刘雪松,杜垣逸,刘云.联合用药对奶牛源乳房链球菌耐药突变选择窗的影响[J].黑龙江畜牧兽医,2020(24):77-82.
-
1邢茂,刘同华,王琴.大环内酯类药物对肺炎链球菌的防耐药突变浓度的研究[J].第三军医大学学报,2009,31(13):1299-1301. 被引量:7
-
2崔俊昌,刘又宁,王睿,梁蓓蓓,郑专杰.氟喹诺酮类药物对临床分离金黄色葡萄球菌的防耐药变异浓度[J].中华医院感染学杂志,2005,15(6):611-614. 被引量:10
-
3孙小芳,黄宏星.有关药物剂量问题的思考[J].中国医药导刊,2005,7(2):155-155. 被引量:2
-
4喻东山.维思通的剂量问题[J].河北精神卫生,1999,12(2):128-129.
-
5段金菊,刘卓拉.变异选择窗口及防耐药变异浓度[J].中国药物与临床,2006,6(11):849-851. 被引量:1
-
6荆靓艳,王慧玲,薛欣,谢广宏.6种氟喹诺酮类药物对凝固酶阴性葡萄球菌的防耐药变异浓度分析[J].中国医药,2012,7(11):1450-1452. 被引量:1
-
7荆靓艳,王慧玲,薛欣,谢广宏.比较6种氟喹诺酮类药物对金黄色葡萄球菌的防耐药变异浓度[J].中国临床药理学杂志,2011,27(9):676-678. 被引量:3
-
8聂大平,薛欣,王玉梅.喹诺酮药物对环丙沙星敏感金黄色葡萄球菌防耐药突变浓度[J].中国感染与化疗杂志,2006,6(1):48-50. 被引量:1
-
9崔俊昌,陈良安.细菌耐药突变选择窗与合理用药[J].中华老年多器官疾病杂志,2007,6(5):293-295. 被引量:4
-
10张育才,王程毅,郑启安.关于甲泼尼龙琥珀酸钠剂量的问题[J].中华儿科杂志,2011,49(5):389-390. 被引量:2